In this report, we offer considerations for the prioritisation of efforts to identify and manage close contacts, as well as indicators for public health authorities in the EU/EEA that can be used for monitoring the efficacy of their contact tracing activities.
The aim of this document is to provide concise advice to public health authorities and guide their prevention, awareness-raising and behaviour change interventions before, during and after upcoming summer events.
This document is intended for health authorities working on RCCE in the context of the current monkeypox outbreak in Europe. It provides advice on approaches to the communication of risks and engagement of population groups based on the outbreak’s epidemiology and context, recommended preventive measures and people’s perceptions and behaviour.
The Protocol is targeted at the national public health reference laboratories to guide the susceptibility testing needed for EU surveillance and the reporting to ECDC.
This document provides laboratories with a single protocol for producing recombinant full-length hamster prion protein and using it to perform the Real-Time Quaking-Induced Conversion assay (RT-QuIC), which can distinguish sporadic Creutzfeldt-Jakob disease (sCJD) from variant Creutzfeldt-Jakob disease (vCJD).
A case of bubonic plague can be suspected on aircraft or ships when a passenger or a crew member leaving an affected area has a fever associated with swollen lymph nodes.
This ECDC expert opinion confirms earlier assessments by ECDC and national authorities that there is no significant new evidence to support any changes to the approved indications and recommended use of neuraminidase inhibitors (NAIs) in EU/EEA Member States.
The aim of this document is to highlight measures that can effectively reduce the risk of importation and local transmission of pathogens transmitted by Ae. aegypti and Ae. albopictus. The main diseases of concern in this context are Zika, dengue, chikungunya and yellow fever.